ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

UNCY Unicycive Therapeutics Inc

0.6503
0.0014 (0.22%)
After Hours
Last Updated: 16:52:10
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Unicycive Therapeutics Inc UNCY NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0014 0.22% 0.6503 16:52:10
Open Price Low Price High Price Close Price Prev Close
0.66 0.641 0.6602 0.6503 0.6489
more quote information »

Recent News

Date Time Source Heading
5/28/202407:03GLOBEUnicycive Therapeutics Delivers Multiple Presentations on..
5/23/202407:03GLOBEUnicycive Therapeutics to Participate in a Fireside Chat at..
5/15/202407:03GLOBEUnicycive Therapeutics Presents Bioequivalence Data on..
5/13/202416:28EDGAR2Form 8-K - Current report
5/13/202416:16GLOBEUnicycive Announces First Quarter 2024 Financial Results and..
5/13/202416:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/08/202416:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
4/10/202407:03GLOBEUnicycive Therapeutics to Present at the Noble Capital..
3/28/202416:15GLOBEUnicycive Therapeutics Announces Full Year 2023 Financial..
3/25/202407:03GLOBEUnicycive Therapeutics to be Featured in Multiple..
3/14/202407:03GLOBEUnicycive Announces $50 Million Private Placement
3/13/202407:03GLOBEUnicycive Therapeutics Delivers Both an Oral and Poster..
3/07/202416:12GLOBEUnicycive Therapeutics Completes Enrollment in Pivotal..
3/04/202407:03GLOBEUnicycive Therapeutics Announces Orphan Drug Designation..
2/21/202416:06EDGAR2Form 8-K - Current report
2/14/202407:03GLOBEUnicycive Therapeutics to Present Two Posters on..
1/29/202407:03GLOBEUnicycive Therapeutics Announces Both an Oral and Poster..
1/23/202407:03GLOBEUnicycive Therapeutics Issues Shareholder Letter to..
1/22/202416:27EDGAR2Form SC 13G - Statement of acquisition of beneficial..
12/18/202307:03GLOBEUnicycive Therapeutics Announces Enrollment of First Patient..
12/08/202316:36EDGAR2Form S-8 - Securities to be offered to employees in employee..
11/29/202307:03GLOBEUnicycive Therapeutics to Participate in Two Investor..
11/14/202316:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/14/202316:15GLOBEUnicycive Announces Third Quarter 2023 Financial Results and..
10/23/202311:12EDGAR2Form 8-K - Current report
10/23/202307:03GLOBEUnicycive Therapeutics Reaches Alignment with the FDA on..
9/25/202316:05EDGAR2Form 8-K - Current report
9/07/202316:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/07/202316:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
9/06/202309:16EDGAR2Form 8-K - Current report
9/06/202307:03GLOBEUnicycive Therapeutics Strengthens Board of Directors with..
8/31/202316:16EDGAR2Form 8-K - Current report
8/30/202316:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/30/202316:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/30/202316:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/29/202307:03GLOBEUnicycive Therapeutics Featured on Nasdaq Amplify Issuer..
8/14/202317:36GLOBEUnicycive Announces Second Quarter 2023 Financial Results..
8/14/202317:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
7/31/202316:15EDGAR2Form 8-K - Current report
7/26/202306:05EDGAR2Form 8-K - Current report
7/20/202307:03GLOBEUnicycive Therapeutics to Participate in the H.C. Wainwright..
7/18/202307:03GLOBEUnicycive Therapeutics Announces Publication of Positive..
7/14/202316:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
7/13/202319:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/13/202319:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/13/202318:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/29/202317:04GLOBEUnicycive Therapeutics Provides Regulatory Update on..

Your Recent History

Delayed Upgrade Clock